Angell is like the financial expert who recommends that a family save money by selling its car forgetting that without a car it makes it much harder to get to work.
Later Angell tries a third claim namely that pharma companies do no innovation because their R&D budget is mostly spent on clinical trials and, “it’s no secret how to do a clinical trial.” I find this line of reasoning bizarre. [....] Angell’s understanding of innovation is cramped and limited, she thinks it begins and ends with basic science in a university lab.
In summary, Marcia Angell seems to understands neither business, nor economics, nor really how science in industry works. Even former interim editors-in-chief of the New England Journal of Medicine can turn out to be bad eggs, er, pennies.